Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Truist Financial
TFC
|
+$1.61B |
| 2 |
Comcast
CMCSA
|
+$1.42B |
| 3 |
Union Pacific
UNP
|
+$961M |
| 4 |
Netflix
NFLX
|
+$930M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$710M |
Top Sells
| 1 |
STI
SunTrust Banks, Inc.
STI
|
+$1.38B |
| 2 |
Bank of New York Mellon
BK
|
+$843M |
| 3 |
Intuit
INTU
|
+$734M |
| 4 |
Johnson & Johnson
JNJ
|
+$714M |
| 5 |
Deere & Co
DE
|
+$590M |
Sector Composition
| 1 | Technology | 20.27% |
| 2 | Healthcare | 16.36% |
| 3 | Financials | 12.47% |
| 4 | Communication Services | 12.35% |
| 5 | Industrials | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Pacific Biosciences
PACB
$369M
| $27.1M | 0.01% |
+5,281,800
| New | +$27.1M |
|
302
Credicorp
BAP
$21.5B
| $26M | 0.01% |
122,200
| – | – |
|
|
SAVE
303
DELISTED
Spirit Airlines, Inc.
SAVE
| $25.8M | 0.01% |
640,200
-232,800
| -27% | -$9.38M |
|
304
Verisk Analytics
VRSK
$35.2B
| $25.4M | 0.01% |
170,084
+96
| +0.1% | +$14.3K |
|
305
FTI Consulting
FCN
$5.3B
| $24M | 0.01% |
217,300
+91,200
| +72% | +$10.1M |
|
306
CRISPR Therapeutics
CRSP
$5.57B
| $22.8M | 0.01% |
375,000
+237,000
| +172% | +$14.4M |
|
|
CCMP
307
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $22.7M | 0.01% |
157,200
+66,000
| +72% | +$9.53M |
|
|
INST
308
DELISTED
Instructure, Inc.
INST
| $22.5M | 0.01% |
+466,200
| New | +$22.5M |
|
309
Generac Holdings
GNRC
$10.8B
| $22.1M | 0.01% |
220,000
| – | – |
|
310
Graco
GGG
$14B
| $21.8M | 0.01% |
420,000
| – | – |
|
311
Cousins Properties
CUZ
$4.92B
| $21.7M | 0.01% |
526,732
+51,200
| +11% | +$2.11M |
|
312
Globant
GLOB
$2.5B
| $21.5M | 0.01% |
+202,931
| New | +$21.5M |
|
313
Weyerhaeuser
WY
$18B
| $21.5M | 0.01% |
712,541
-500,000
| -41% | -$15.1M |
|
314
MGIC Investment
MTG
$6.43B
| $21.4M | 0.01% |
1,509,039
| – | – |
|
|
NFH
315
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
| $21.2M | 0.01% |
+2,128,000
| New | +$21.2M |
|
316
Yext
YEXT
$1.08B
| $21M | 0.01% |
1,454,400
| – | – |
|
|
INXN
317
DELISTED
Interxion Holding N.V.
INXN
| $21M | 0.01% |
250,000
| – | – |
|
318
Flex
FLEX
$21.4B
| $20.9M | 0.01% |
2,202,157
| – | – |
|
319
Idexx Laboratories
IDXX
$51.7B
| $20.5M | 0.01% |
78,497
+1,851
| +2% | +$483K |
|
320
KT
KT
$9.65B
| $20M | 0.01% |
1,726,783
+3,349
| +0.2% | +$38.8K |
|
321
Dell
DELL
$85.8B
| $19.9M | 0.01% |
763,748
| – | – |
|
322
Datadog
DDOG
$46.9B
| $18.9M | 0.01% |
500,088
+88
| +0% | +$3.33K |
|
|
RVNC
323
DELISTED
Revance Therapeutics, Inc.
RVNC
| $18.9M | 0.01% |
1,161,900
+836,900
| +258% | +$13.6M |
|
324
PPL Corp
PPL
$26.2B
| $18.8M | 0.01% |
523,133
+532
| +0.1% | +$19.1K |
|
325
Adaptive Biotechnologies
ADPT
$1.97B
| $18M | 0.01% |
600,000
| – | – |
|